InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
69,062.28
(
0.78%
)
Post# of 6280
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rickh

Send PM Follow Ignore
Followers 2
Posts 23
Boards Moderated 0
Alias Born 10/08/2001

rickh

Re: None

Monday, 08/26/2013 10:01:42 AM

Monday, August 26, 2013 10:01:42 AM

Post# of 6280
Piper Raises Avanir (AVNR) Target to $13

http://streetinsider.com/r/8632942

Piper Jaffray maintained an Overweight rating on Avanir Pharmaceuticals (NASDAQ: AVNR) and boosted its price target to $13.00 (from $6.00). Analyst Charles Duncan thinks its next-generations AVP-786 will be differentiated from Nuedexta generics, fueling expansion through 2030.

For an analyst ratings summary and ratings history on Avanir Pharmaceuticals click here. For more ratings news on Avanir Pharmaceuticals click here.

Shares of Avanir Pharmaceuticals closed at $4.98 yesterday, with a 52 week range of $2.07-$5.27.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up